Engineered Protein Photo‐Thermal Hydrogels for Outstanding In Situ Tongue Cancer Therapy
Source abstract
Abstract
Abstract Surgical excision is the main choice for tongue cancer treatment. However, the physiological functions of oral and maxillofacial regions might be severely impaired and high risk of tongue tumor recurrence cannot be avoided. It is thus becoming urgently important to develop alternative strategies for tongue cancer therapy. In this regard, a new class of near‐infrared (NIR) light‐responsive and peritumoral injectable hydrogel is fabricated with extraordinary photothermal therapy (PTT) for in situ tongue tumors. The as‐prepared soft material exhibits good biocompatibility and ultra‐strong photothermal effect due to the formed network by negatively charged proteins, chitosan molecules, and Ag3AuS2 nanoparticles (NPs). In a well‐constructed in situ tongue tumor model, tumors can be efficiently eradicated by one‐time PTT treatment. Importantly, there are no side effects on surrounding normal tissues and potential tumor recurrence is inhibited. In stark contrast to traditional surgical excision, such biomaterials hold great potential for clinical treatment of oral cancers.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Polydiacetylene-based materials and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Rare Earth Resource Utilization Changchun Institute of Applied Chemistry Chinese Academy of Sciences Changchun 130022 China
College of Materials Science and Opto‐Electronic Technology University of Chinese Academy of Sciences Beijing 100049 China
Department of Geriatric Dentistry Beijing Laboratory of Biomedical Materials Peking University School and Hospital of Stomatology Beijing 100081 China
Funding
K. C. Wong Education Foundation · National Natural Science Foundation of China
References (36)
Show source-provided references
1. 10.1038/nrc2982-c110.1038/nrc2982-c1 ↗
2. 10.1002/smll.20180549210.1002/smll.201805492 ↗
3. 10.1002/ijc.3010710.1002/ijc.30107 ↗
4. 10.1016/j.ijrobp.2010.09.03810.1016/j.ijrobp.2010.09.038 ↗
5. 10.1002/jso.2499110.1002/jso.24991 ↗
6. 10.1016/j.media.2014.11.00610.1016/j.media.2014.11.006 ↗
7. 10.2147/OTT.S16923110.2147/OTT.S169231 ↗
8. 10.1002/anie.20191207210.1002/anie.201912072 ↗
9. 10.1016/j.radonc.2017.05.00110.1016/j.radonc.2017.05.001 ↗
10. 10.1158/1078-0432.CCR-11-004610.1158/1078-0432.CCR-11-0046 ↗
11. 10.1155/2020/564917410.1155/2020/5649174 ↗
12. 10.1002/adfm.20191030110.1002/adfm.201910301 ↗
13. 10.1002/advs.20190257610.1002/advs.201902576 ↗
14. 10.1002/smll.20180299410.1002/smll.201802994 ↗
15. 10.1002/adma.20170598010.1002/adma.201705980 ↗
16. 10.1002/anie.20180051110.1002/anie.201800511 ↗
17. 10.1016/j.cej.2020.12426810.1016/j.cej.2020.124268 ↗
18. 10.7150/thno.3026810.7150/thno.30268 ↗
19. 10.7150/thno.1345110.7150/thno.13451 ↗
20. 10.1016/j.ijpharm.2018.10.06410.1016/j.ijpharm.2018.10.064 ↗
21. 10.1039/C8NR07627H10.1039/C8NR07627H ↗
22. 10.1021/acs.chemmater.7b0144910.1021/acs.chemmater.7b01449 ↗
23. 10.1002/anie.20200956910.1002/anie.202009569 ↗
24. 10.1002/anie.20200767610.1002/anie.202007676 ↗
25. 10.1002/anie.20200239910.1002/anie.202002399 ↗
26. 10.1002/adma.20200096410.1002/adma.202000964 ↗
27. 10.1002/adma.20200446010.1002/adma.202004460 ↗
28. 10.1002/anie.20191239910.1002/anie.201912399 ↗
29. L J. · CCS Chem. · 2020 · 2 · 1830
30. 10.1021/nn402601d10.1021/nn402601d ↗
31. 10.1002/anie.20150615410.1002/anie.201506154 ↗
32. 10.1016/j.biomaterials.2014.12.03710.1016/j.biomaterials.2014.12.037 ↗
33. 10.1021/acs.nanolett.6b0059910.1021/acs.nanolett.6b00599 ↗
34. 10.1021/acsanm.0c0204410.1021/acsanm.0c02044 ↗
35. 10.1039/C4NR00708E10.1039/C4NR00708E ↗
36. 10.1016/j.semcdb.2016.09.00510.1016/j.semcdb.2016.09.005 ↗